IMHO, the success will come from well thought out multi channel distributed marketing.
Dolphin needs to find pharma. companies in various markets around the world to distribute ReCell, and let them absorb the distribution and marketing costs. These companies must have current partnerships/relationships with the end users of ReCell,ie. hospitals, cosmetic surgeons, etc.
Avita cannot and should not try to distribute directly to end users, that would be financial disaster, it doesnt have the resources to effective maximises sales potentials of ReCell via direct marketing.
Has there been any distribution agreements signed with any major pharma. company???
Just my 2cents worth.
success of avh marketing
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.74 |
Change
0.250(10.0%) |
Mkt cap ! $170.3M | |||
| Open | High | Low | Value | Volume |
| $2.56 | $2.78 | $2.56 | $2.148M | 794.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 911 | $2.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.75 | 7135 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.76 |
Change
0.250 ( 10.1 %) |
||||
| Open | High | Low | Volume | ||
| $2.59 | $2.78 | $2.59 | 31457 | ||
| Last updated 15.58pm 29/05/2024 ? | |||||
| AVH (ASX) Chart |